New York is expanding testing of newborns in 2022 to include screening for a range of potentially debilitating genetic conditions, with an emphasis on disorders common among certain ethnic and ...

Newborn screening (NBS) is routinely performed across the world using biochemical testing methods. Recent advancements in genetic sequencing are a potential game-changer for newborn screening, swiftly ...

Objective: Jaundice is a common disorder in neonates and G6PD deficiency could result in kernicterus. The aim of This study was to compare of G6PD mutation in icteric and non icteric neonates. Methods ...

Newborn screening for an inherited genetic condition that affects people of several ethnicities could reduce the risk of long-term disability for many on Long Island, doctors and advocates say.

Download the latest edition 3. A total of 445 newborns were diagnosed with 13 disorders screened by both genetic and biochemical NBS, which included G6PD deficiency (328 newborns), congenital ...

It's a blood test that measures the amount of glucose-6-phosphate dehydrogenase (G6PD) in your body. G6PD is an enzyme that helps your red blood cells work properly. If your G6PD level is too low, you ...

The Karnataka government has accorded administrative approval to implement universal newborn screening for congenital and metabolic disorders in the Kalyana Karnataka region at a cost of ₹5.58 crore ...